KEBILIDI™ (eladocagene exuparvovec-tneq) is a gene therapy for AADC deficiency. It enables brain cells to make a working AADC protein needed for motor function.
Sickle cell disease is an inherited blood disorder where cells cluster together, making it difficult for them to move through small blood vessels, thus denying oxygen to the blood.
ZYNTEGLO™, also called beti-cel (betibeglogene autotemcel), is a gene therapy for children and adults with beta-thalassemia who require regular transfusions of red blood cells.